Newly Formed Lanier Biotherapeutics Enters into License Agreement with Alloy Therapeutics
October 05, 2021 08:00 ET
|
Lanier Biotherapeutics
BOGART, Ga., Oct. 05, 2021 (GLOBE NEWSWIRE) -- Lanier Biotherapeutics Inc., (“Lanier” or the “Company”), a developer of first-in-class antibodies targeting retina, dermatology, and Type 2...
Graybug Vision to Participate in the Annual Ophthalmology Innovation Summit (OIS) Retina@ASRS Conference
September 30, 2021 16:05 ET
|
Graybug Vision, Inc.
BALTIMORE, Sept. 30, 2021 (GLOBE NEWSWIRE) -- Graybug Vision, Inc. (Nasdaq: GRAY), a clinical-stage biopharmaceutical company focused on developing transformative medicines for the treatment of...
Worldwide Choroidal Neovascularization Industry to 2026 - Featuring Novartis, Pfizer and Regeneron Pharmaceuticals Among Others
September 30, 2021 06:53 ET
|
Research and Markets
Dublin, Sept. 30, 2021 (GLOBE NEWSWIRE) -- The "Choroidal Neovascularization Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026" report has been added to...
Graybug Vision Reports Analysis of Data from the Six-Month Extension Study of the ALTISSIMO Phase 2b Trial in Wet AMD
September 28, 2021 07:30 ET
|
Graybug Vision, Inc.
55% of GB-102 1mg patients in Extension Study experienced duration of 12+ months, while maintaining their visual acuity and central retinal thickness73% reduction of injection burden for patients...
Graybug Vision to Participate in the Cantor Virtual Global Healthcare Conference
September 21, 2021 17:15 ET
|
Graybug Vision, Inc.
BALTIMORE, Sept. 21, 2021 (GLOBE NEWSWIRE) -- Graybug Vision, Inc. (Nasdaq: GRAY), a clinical-stage biopharmaceutical company focused on developing transformative medicines for the treatment of...
Cross Keys Capital Advises Rockland Retina on Its Sale to Retina Consultants of America
September 21, 2021 09:00 ET
|
Cross Keys Capital, LLC.
Fort Lauderdale, Sept. 21, 2021 (GLOBE NEWSWIRE) -- Cross Keys Capital served as the exclusive sell-side M&A advisor to Rockland Retina (RR) in its partnership with Retina Consultants of America...
Worldwide Diabetic Retinopathy Industry to 2026 - by Type, Treatment Type, End-user and Region
August 16, 2021 08:38 ET
|
Research and Markets
Dublin, Aug. 16, 2021 (GLOBE NEWSWIRE) -- The "Diabetic Retinopathy Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026" report has been added to...
Graybug Vision Announces Financial Results for the Three and Six Months Ended June 30, 2021, and Recent Corporate Developments
August 11, 2021 16:05 ET
|
Graybug Vision, Inc.
REDWOOD CITY, Calif., Aug. 11, 2021 (GLOBE NEWSWIRE) -- Graybug Vision, Inc. (Nasdaq: GRAY), a clinical-stage biopharmaceutical company focused on developing transformative medicines for the...
Graybug Vision to Participate in the 2021 Wedbush PacGrow Healthcare Virtual Conference
August 04, 2021 07:30 ET
|
Graybug Vision, Inc.
REDWOOD CITY, Calif., Aug. 04, 2021 (GLOBE NEWSWIRE) -- Graybug Vision, Inc. (Nasdaq: GRAY), a clinical-stage biopharmaceutical company focused on developing transformative medicines for the...
Notal Vision announces publication of first prospective longitudinal pilot study of daily self-imaging with patient-operated Home OCT in wet AMD patients
July 13, 2021 08:00 ET
|
Notal Vision
Manassas, VA, July 13, 2021 (GLOBE NEWSWIRE) -- Notal Vision, Inc. announced today that results from the first prospective longitudinal pilot study of daily, home-based self-imaging with their...